Somatization: The under-recognized factor in nonspecific eczema. the Hordaland Health Study (HUSK)

British Journal of Dermatology

Volumn 164, Issue 3, 2011, Pages 593-601

  Klokk, M ^a,b   Stansfeld, S ^c   Overland S ^d   Wilhelmsen, I ^d   Gotestam, K G ^b   Steinshamn, S ^b,e   Mykletun, A ^d,f  

^a Aalesund Hospital   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF BERGEN   (Norway)

^e TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^f NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLERGIC RHINITIS; ANXIETY; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; ECZEMA; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; SOCIAL ASPECT; SOMATIZATION;

ADULT; ANXIETY; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; ECZEMA; FEMALE; HUMANS; MALE; MIDDLE AGED; SOMATOFORM DISORDERS;

EID: 79952394854     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.10150.x     Document Type: Article

References (71)

1. Koblenzer CS,. Psychodermatology of women. Clin Dermatol 1997; 15: 127-41. (Pubitemid 27082294)
2. Koblenzer CS,. Psychosomatic concepts in dermatology. A dermatologist-psychoanalyst's viewpoint. Arch Dermatol 1983; 119: 501-12. (Pubitemid 13100117)
3. Gupta MA,. Somatization disorders in dermatology. Int Rev Psychiatry 2006; 18: 41-7. (Pubitemid 43201020)
4. Woodruff PW, Higgins EM, du Vivier AW, et al. Psychiatric illness in patients referred to a dermatology-psychiatry clinic. Gen Hosp Psychiatry 1997; 19: 29-35. (Pubitemid 27063598)
5. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization, 1992.
6. Ladwig KH, Marten-Mittag B, Erazo N, et al. Identifying somatization disorder in a population-based health examination survey: psychosocial burden and gender differences. Psychosomatics 2001; 42: 511-18. (Pubitemid 34084253)
7. Lieb R, Pfister H, Mastaler M, et al. Somatoform syndromes and disorders in a representative population sample of adolescents and young adults: prevalence, comorbidity and impairments. Acta Psychiatr Scand 2000; 101: 194-208. (Pubitemid 30108370)
8. Faravelli C, Salvatori S, Galassi F, et al. Epidemiology of somatoform disorders: a community survey in Florence. Soc Psychiatry Psychiatr Epidemiol 1997; 32: 24-9. (Pubitemid 27029770)
9. Janca A, Isaac M, Ventouras J,. Towards better understanding and management of somatoform disorders. Int Rev Psychiatry 2006; 18: 5-12. (Pubitemid 43201016)
10. Barsky AJ, Borus JF,. Somatization and medicalization in the era of managed care. JAMA 1995; 274: 1931-4. (Pubitemid 26003063)
11. Brown RJ,. Psychological mechanisms of medically unexplained symptoms: an integrative conceptual model. Psychol Bull 2004; 130: 793-812. (Pubitemid 39216583)
12. Fink P, Sorensen L, Engberg M, et al. Somatization in primary care. Prevalence, health care utilization, and general practitioner recognition. Psychosomatics 1999; 40: 330-8. (Pubitemid 29315955)
13. Smith GR Jr,. The course of somatization and its effects on utilization of health care resources. Psychosomatics 1994; 35: 263-7. (Pubitemid 24134503)
14. Mykletun A, Heradstveit O, Eriksen K, et al. Health anxiety and disability pension award: the HUSK Study. Psychosom Med 2009; 71: 353-60.
15. Lipowski ZJ,. Somatization: the concept and its clinical application. Am J Psychiatry 1988; 145: 1358-68. (Pubitemid 18267374)
16. Katon W, Lin E, von Korff M, et al. Somatization: a spectrum of severity. Am J Psychiatry 1991; 148: 34-40.
17. Friedman BS, Germano P, Miletti J, et al. A clinicopathologic study of ten patients with recurrent unexplained flushing. J Allergy Clin Immunol 1994; 93: 53-60.
18. Zafiriou E, Angelopoulos NV, Zintzaras E, et al. Psychiatric factors in patients with sensitive skin. Drugs Exp Clin Res 2005; 31 (Suppl.): 25-30. (Pubitemid 43139618)
19. Harvima RJ, Viinamaki H, Harvima IT, et al. Association of psychic stress with clinical severity and symptoms of psoriatic patients. Acta Derm Venereol 1996; 76: 467-71. (Pubitemid 26398097)
20. Sivik T,. Alexithymia and hypersensitivity to touch and palpation. Integr Physiol Behav Sci 1993; 28: 130-6.
21. Picardi A, Porcelli P, Pasquini P, et al. Integration of multiple criteria for psychosomatic assessment of dermatological patients. Psychosomatics 2006; 47: 122-8. (Pubitemid 43346959)
22. Wessely S, Nimnuan C, Sharpe M,. Functional somatic syndromes: one or many? Lancet 1999; 354: 936-9. (Pubitemid 29424033)
23. Kapoor R, Menon C, Hoffstad O, et al. The prevalence of atopic triad in children with physician-confirmed atopic dermatitis. J Am Acad Dermatol 2008; 58: 68-73. (Pubitemid 350298135)
24. Sivertsen B, Overland S, Neckelmann D, et al. The long-term effect of insomnia on work disability: the HUNT-2 historical cohort study. Am J Epidemiol 2006; 163: 1018-24. (Pubitemid 43987594)
25. Sanne B, Mykletun A, Dahl AA, et al. Occupational differences in levels of anxiety and depression: the Hordaland Health Study. J Occup Environ Med 2003; 45: 628-38. (Pubitemid 36702679)
26. Moen BE, Hollund BE, Torp S,. A descriptive study of health problems on car mechanics' hands. Occup Med (Lond) 1995; 45: 318-22.
27. Meding B,. Epidemiology of hand eczema in an industrial city. Acta Derm Venereol 1990; 153 (Suppl.): 1-43. (Pubitemid 20215318)
28. Meding B, Barregard L, Marcus K,. Hand eczema in car mechanics. Contact Dermatitis 1994; 30: 129-34. (Pubitemid 24075409)
29. Meding B, Barregard L,. Validity of self-reports of hand eczema. Contact Dermatitis 2001; 45: 99-103. (Pubitemid 32738428)
30. Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113: 832-6. (Pubitemid 38608590)
31. Klokk M, Gotestam KG, Mykletun A,. Factors accounting for the association between anxiety and depression, and eczema: the Hordaland Health Study (HUSK). BMC Dermatol 2010; 10: 3.
32. Zigmond AS, Snaith RP,. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-70. (Pubitemid 13098606)
33. Mykletun A, Stordal E, Dahl AA,. Hospital Anxiety and Depression (HAD) scale: factor structure, item analyses and internal consistency in a large population. Br J Psychiatry 2001; 179: 540-4. (Pubitemid 34031681)
34. Pilowsky I,. Dimensions of hypochondriasis. Br J Psychiatry 1967; 113: 89-93.
35. Hiller W, Rief W, Fichter MM,. Dimensional and categorical approaches to hypochondriasis. Psychol Med 2002; 32: 707-18. (Pubitemid 34495688)
36. Haenen MA, Schmidt AJ, Kroeze S, et al. Hypochondriasis and symptom reporting-the effect of attention versus distraction. Psychother Psychosom 1996; 65: 43-8. (Pubitemid 26041208)
37. Steptoe A, Noll A,. The perception of bodily sensations, with special reference to hypochondriasis. Behav Res Ther 1997; 35: 901-10. (Pubitemid 27489118)
38. Harrop J, Chinn S, Verlato G, et al. Eczema, atopy and allergen exposure in adults: a population-based study. Clin Exp Allergy 2007; 37: 526-35. (Pubitemid 46537740)
39. Kavli G, Forde OH,. Hand dermatoses and sick-leave: relationship between educational level, physical activity at work and housework as main occupation. Contact Dermatitis 1984; 11: 70-3. (Pubitemid 14085450)
40. Andersen KE,. Occupational issues of allergic contact dermatitis. Int Arch Occup Environ Health 2003; 76: 347-50. (Pubitemid 37006276)
41. Sinaii N, Cleary SD, Ballweg ML, et al. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Hum Reprod 2002; 17: 2715-24. (Pubitemid 35174127)
42. Kokkonen J, Niinimaki A,. Increased incidence of autoimmune disorders as a late complication in children with early onset dermatitis and/or milk allergy. J Autoimmun 2004; 22: 341-4. (Pubitemid 38543226)
43. Overland S, Glozier N, Maeland JG, et al. Employment status and perceived health in the Hordaland Health Study (HUSK). BMC Public Health 2006; 6: 219.
44. World Health Organization. Anatomical, Therapeutic, Chemical (ATC) Classification Index with Defined Daily Doses (DDDs). Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 1998.
45. WONCA International Classification Committee. ICPC-2. International Classification of Primary Care. Prepared by the Classification Committee of WONCA. Oxford: Oxford University Press, 1998.
46. Plunkett A, Merlin K, Gill D, et al. The frequency of common nonmalignant skin conditions in adults in central Victoria Australia. Int J Dermatol 1999; 38: 901-8. (Pubitemid 30002738)
47. Mykletun A, Bjerkeset O, Overland S, et al. Levels of anxiety and depression as predictors of mortality: the HUNT study. Br J Psychiatry 2009; 195: 118-25.
48. Eaton WW, Anthony JC, Tepper S, et al. Psychopathology and attrition in the epidemiologic catchment area surveys. Am J Epidemiol 1992; 135: 1051-9.
49. Timonen M, Hakko H, Miettunen J, et al. Association between atopic disorders and depression: findings from the Northern Finland 1966 Study Birth Cohort. Am J Med Genet 2001; 105: 216-17. (Pubitemid 32290590)
50. Timonen M, Jokelainen J, Hakko H, et al. Atopy and depression: results from the Northern Finland 1966 Study Birth Cohort. Mol Psychiatry 2003; 8: 738-44. (Pubitemid 36976431)
51. Timonen M, Jokelainen J, Herva A, et al. Presence of atopy in first-degree relatives as a predictor of a female proband's depression: results from the Northern Finland 1966 Cohort Birth. J Allergy Clin Immunol 2003; 111: 1249-54. (Pubitemid 36683678)
52. Timonen M, Jokelainen J, Silvennoinen-Kassinen S, et al. Association between skin test diagnosed atopy and professionally diagnosed depression: a Northern Finland 1966 Birth Cohort Study. Biol Psychiatry 2002; 52: 349-55. (Pubitemid 35245974)
53. Garrie SA, Garrie EV,. Anxiety and skin diseases. Cutis 1978; 22: 205-8.
54. Gupta MA, Gupta AK,. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998; 139: 846-50. (Pubitemid 28520293)
55. Hashiro M, Okumura M,. Anxiety, depression and psychosomatic symptoms in patients with atopic dermatitis: comparison with normal controls and among groups of different degrees of severity. J Dermatol Sci 1997; 14: 63-7. (Pubitemid 27065250)
56. Hashizume H, Takigawa M,. Anxiety in allergy and atopic dermatitis. Curr Opin Allergy Clin Immunol 2006; 6: 335-9. (Pubitemid 44368239)
57. Linnet J, Jemec GB,. An assessment of anxiety and dermatology life quality in patients with atopic dermatitis. Br J Dermatol 1999; 140: 268-72. (Pubitemid 29111355)
58. Zachariae R, Zachariae C, Ibsen HH, et al. Psychological symptoms and quality of life of dermatology outpatients and hospitalized dermatology patients. Acta Derm Venereol 2004; 84: 205-12. (Pubitemid 38649398)
59. Niemeier V, Nippesen M, Kupfer J, et al. Psychological factors associated with hand dermatoses: which subgroup needs additional psychological care? Br J Dermatol 2002; 146: 1031-7. (Pubitemid 34779484)
60. Jowett S, Ryan T,. Skin disease and handicap: an analysis of the impact of skin conditions. Soc Sci Med 1985; 20: 425-9. (Pubitemid 15235778)
61. Kuruvila M, Gahalaut P, Zacharia A,. A study of skin disorders in patients with primary psychiatric conditions. Indian J Dermatol Venereol Leprol 2004; 70: 292-5.
62. Haddad JJ,. Cytokines and related receptor-mediated signaling pathways. Biochem Biophys Res Commun 2002; 297: 700-13. (Pubitemid 35230308)
63. Wilson CJ, Finch CE, Cohen HJ,. Cytokines and cognition-the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc 2002; 50: 2041-56. (Pubitemid 35462453)
64. Numerof RP, Asadullah K,. Cytokine and anti-cytokine therapies for psoriasis and atopic dermatitis. BioDrugs 2006; 20: 93-103.
65. Dantzer R,. Somatization: a psychoneuroimmune perspective. Psychoneuroendocrinology 2005; 30: 947-52. (Pubitemid 40982477)
66. Ehlers A, Stangier U, Gieler U,. Treatment of atopic dermatitis: a comparison of psychological and dermatological approaches to relapse prevention. J Consult Clin Psychol 1995; 63: 624-35.
67. Horne DJ, White AE, Varigos GA,. A preliminary study of psychological therapy in the management of atopic eczema. Br J Med Psychol 1989; 62: 241-8.
68. Cole WC, Roth HL, Sachs LB,. Group psychotherapy as an aid in the medical treatment of eczema. J Am Acad Dermatol 1988; 18: 286-91. (Pubitemid 18061196)
69. Koblenzer CS,. Psychotherapy for intractable inflammatory dermatoses. J Am Acad Dermatol 1995; 32: 609-12.
70. Kroenke K,. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med 2007; 69: 881-8. (Pubitemid 350158831)
71. Sumathipala A,. What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosom Med 2007; 69: 889-900. (Pubitemid 350161711)